| Hepatocellular Carcinoma |
1 |
1 |
| Hepatitis C Virus |
0 |
0.99 |
| Cancer |
0 |
0.71 |
| Biliary Disease |
0 |
0.64 |
| Cancer Risk |
0 |
0.51 |
| Liver |
0 |
0.5 |
| Hepatitis |
0 |
0.4 |
| Fatty Liver |
0 |
0.37 |
| Liver Disease |
0 |
0.37 |
| Metabolic Syndrome |
0 |
0.35 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.35 |
| Cirrhosis |
0 |
0.34 |
| Liver Tumor |
0 |
0.32 |
| Antiviral Agents |
0 |
0.31 |
| COVID-19 |
0 |
0.27 |
| Preventive Screening |
0 |
0.09 |
| Alcohol Use |
0 |
0.06 |
| Biomarker |
0 |
0.06 |
| Washington |
0 |
0.06 |
| Electronic Health Record (EHR) |
0 |
0.03 |
| Electronic Medical Record |
0 |
0.03 |
| Fellowship |
0 |
0.03 |
| Geriatrics |
0 |
0.03 |
| Grant |
0 |
0.03 |
| Health Administration |
0 |
0.03 |
| Pandemic |
0 |
0.03 |
| Texas |
0 |
0.03 |
| Transplantation |
0 |
0.03 |
| Tumor |
0 |
0.03 |
| Viral Load |
0 |
0.03 |
| Weight Management |
0 |
0.03 |